Artificial intelligence integrated scattering type near field optical microscopy for early and transformative cancer detection

The VILNIAUS UNIVERSITETAS in Belgium from Europe region has released this tender for Artificial intelligence integrated scattering type near field optical microscopy for early and transformative cancer detection AI-SCAN aims to revolutionize the field of cancer diagnostics by merging the analytical power of artificial intelligence AI with the ultra-high spatial resolution of scattering-type near-field optical microscopy SNOM for cancer detection Cancer cells undergo biochemical and morphological alterations at the nanoscale such as changes in DNA protein content lipid distribution refractive index RI and membrane architecture Detecting and interpreting these subtle variations before they observable at the tissue or organ level remains one of the greatest challenges in early diagnosis AI-SCAN directly addresses this challenge by developing intelligent computational models capable of decoding complex nanoscale optical signals and identifying disease-specific biomarkers with unprecedented sensitivity and accuracy The project integrates three complementary components First physics-based three-dimensional 3D simulation models will be established to reproduce the interaction between light SNOM probe and biological samples Second advanced SNOM imaging will be employed to acquire real time high-quality spectroscopic and topographic data from healthy and cancerous cells Third cutting-edge AI algorithms like BRANN will be utilized to extract diagnostically relevant features from multimodal SNOM datasets enabling robust classification of healthy versus malignant states Through this multidisciplinary approach AI-SCAN seeks to establish a new paradigm for nanoscale cancer detection The combination of experimental measurements computational simulations and AI analysis will allow systematic identification of optical biomarkers that are otherwise hidden within noisy and high-dimensional datasets Ultimately AI-SCAN has the potential to pave the way for earlier and more accurate detection of aggressive cancers contributing to the advancement of biomedical imaging and strengthening Europe s leadership in AI-driven healthcare innovation with tender notice no. 101276151 published on 21 Aug 2026. The tender is due to expire on 31 Dec 2028. This tender is sourced from Cordis and is eligible for suppliers interested in Artificial Intelligence, Medical software package, DNA, Optical microscopes. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 14474929.